Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jua Choi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical Transplants|May 18, 2017
Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials ProcessStanley C Jordan, Jua Choi, Ashley Vo
Immunotherapy|April 29, 2015
Achieving incompatible transplantation through desensitization: current perspectives and future directionsStanley C Jordan, Jua Choi, Ashley Vo
British Medical Bulletin|May 4, 2015
Kidney transplantation in highly sensitized patientsStanley C Jordan, Jua Choi, Ashley Vo
Clinical Transplants|May 18, 2017
Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney TransplantationJoseph Kahwaji, Jua Choi, Ashley Vo, et al.
Journal of Immunology Research|January 28, 2017
Desensitization: Overcoming the Immunologic Barriers to TransplantationSupreet Sethi, Jua Choi, Mieko Toyoda, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
Transplantation|August 1, 2020
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In VitroShili Ge, Maggie Chu, Jua Choi, et al.
Transplantation|August 23, 2016
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor BlockadeStanley C Jordan, Jua Choi, Irene Kim, et al.
BMC Geriatrics|July 10, 2013
Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort studyJeff Borenstein, Harriet Udin Aronow, Linda Burnes Bolton, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical Transplants|May 18, 2017
Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials ProcessStanley C Jordan, Jua Choi, Ashley Vo
Immunotherapy|April 29, 2015
Achieving incompatible transplantation through desensitization: current perspectives and future directionsStanley C Jordan, Jua Choi, Ashley Vo
British Medical Bulletin|May 4, 2015
Kidney transplantation in highly sensitized patientsStanley C Jordan, Jua Choi, Ashley Vo
Clinical Transplants|May 18, 2017
Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney TransplantationJoseph Kahwaji, Jua Choi, Ashley Vo, et al.
Journal of Immunology Research|January 28, 2017
Desensitization: Overcoming the Immunologic Barriers to TransplantationSupreet Sethi, Jua Choi, Mieko Toyoda, et al.
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
Transplantation|August 1, 2020
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In VitroShili Ge, Maggie Chu, Jua Choi, et al.
Transplantation|August 23, 2016
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor BlockadeStanley C Jordan, Jua Choi, Irene Kim, et al.
BMC Geriatrics|July 10, 2013
Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort studyJeff Borenstein, Harriet Udin Aronow, Linda Burnes Bolton, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Pageof 4